1. Home
  2. WST vs RTO Comparison

WST vs RTO Comparison

Compare WST & RTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • RTO
  • Stock Information
  • Founded
  • WST 1923
  • RTO 1925
  • Country
  • WST United States
  • RTO United Kingdom
  • Employees
  • WST N/A
  • RTO N/A
  • Industry
  • WST Medical/Dental Instruments
  • RTO Business Services
  • Sector
  • WST Health Care
  • RTO Consumer Discretionary
  • Exchange
  • WST Nasdaq
  • RTO Nasdaq
  • Market Cap
  • WST 15.2B
  • RTO 12.2B
  • IPO Year
  • WST N/A
  • RTO N/A
  • Fundamental
  • Price
  • WST $214.58
  • RTO $23.38
  • Analyst Decision
  • WST Strong Buy
  • RTO Hold
  • Analyst Count
  • WST 6
  • RTO 1
  • Target Price
  • WST $349.00
  • RTO N/A
  • AVG Volume (30 Days)
  • WST 1.0M
  • RTO 999.1K
  • Earning Date
  • WST 04-24-2025
  • RTO 03-26-2025
  • Dividend Yield
  • WST 0.39%
  • RTO 2.51%
  • EPS Growth
  • WST N/A
  • RTO N/A
  • EPS
  • WST 6.37
  • RTO 0.15
  • Revenue
  • WST $2,895,800,000.00
  • RTO $6,805,463,398.00
  • Revenue This Year
  • WST $1.24
  • RTO $9.38
  • Revenue Next Year
  • WST $6.56
  • RTO $3.78
  • P/E Ratio
  • WST $33.44
  • RTO $30.46
  • Revenue Growth
  • WST N/A
  • RTO 1.14
  • 52 Week Low
  • WST $187.43
  • RTO $19.60
  • 52 Week High
  • WST $372.79
  • RTO $34.07
  • Technical
  • Relative Strength Index (RSI)
  • WST 50.21
  • RTO 54.39
  • Support Level
  • WST $204.79
  • RTO $23.20
  • Resistance Level
  • WST $215.05
  • RTO $24.27
  • Average True Range (ATR)
  • WST 7.23
  • RTO 0.45
  • MACD
  • WST 1.16
  • RTO 0.11
  • Stochastic Oscillator
  • WST 63.32
  • RTO 56.37

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About RTO Rentokil Initial plc

Rentokil Initial is the largest global provider of route-based pest-control and commercial hygiene services, operating in 83 countries. The group also offers a range of specialist route-based services including office and commercial space plant care, property care, and workwear rentals. The group has a diverse client base that includes global food producers, hotel chains, industrial goods businesses, restaurants, and individual residential customers.

Share on Social Networks: